FDA Drug Application (022426) for OSENI by TAKEDA PHARMS USA

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Application Number022426
Product Number001
FormTABLET;ORAL
DosageEQ 25MG BASE;EQ 15MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameOSENI
Active IngredientALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE



Back to FDA Applications sponsored by TAKEDA PHARMS USA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.